MOUNTAIN VIEW, Calif.,
May 28, 2015 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), today announced that
on May 20, 2015, plaintiff
Jeffrey Nelson voluntarily dismissed
his action, Nelson v. Omnicell, Inc., et al., 15-CV-01280, brought
before the Northern District Court of California, without prejudice, as to all
defendants. Mr. Nelson purported to file a class action
lawsuit on behalf of all Omnicell shareholders who purchased stock
between May 2, 2014 and March 2, 2015.
With the dismissal of the Nelson lawsuit, no pending class
action lawsuits are outstanding, following the resolution of
Omnicell's recent whistleblower investigation that had postponed
the filing of the Company's 2014 Annual Report on Form 10-K until
March 30, 2015.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new
efficiencies to improve patient care, anywhere it is delivered.
Omnicell is a leading supplier of comprehensive automation and
business analytics software for patient-centric medication and
supply management across the entire healthcare continuum— from the
acute care hospital setting to post-acute skilled nursing and
long-term care facilities to the home.
More than 3,000 customers worldwide have utilized Omnicell
Automation and Analytics solutions to increase operational
efficiency, reduce errors, deliver actionable intelligence and
improve patient safety. Omnicell Medication Adherence solutions,
including its MTS Medication Technologies brand, provide innovative
medication adherence packaging solutions to help reduce costly
hospital readmissions. In addition, these solutions enable
approximately 6,000 institutional and retail pharmacies worldwide
to maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
OMCL-E
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-announces-voluntary-dismissal-of-shareholder-lawsuit-300089636.html
SOURCE Omnicell, Inc.